Back to calendar
Ligand Pharmaceuticals Incorporated (LGND) Earnings
LGND reports earnings on Tuesday, August 11, 2026
earnings report
August 11, 2026 · Before Market Open
Q2 2026
Est. EPS: $1.92
Actual EPS: $1.63
EPS surprise: -10.23%
Company overview
Market Cap$5.9B
PriceUSD 295.15
P/E40.02
EPS (TTM)7.38
52-week high326.63
52-week low129.47
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees47